Dr. Miriam von Felbert takes over as Director of +49 med and patient+, leading the strategic development of good healthcare group with a focus on team building, structure, and growth.
Roche announces the return of Nina Schwab-Hautzinger as the new Head of Group Communications. She will join the Enlarged Corporate Executive Committee in February 2026.
Novartis Germany has appointed Manfred Heinzer as the new Chairman of the Management Board. He succeeds Heinrich Moisa and brings over 30 years of international pharmaceutical experience.
Burda Media continues its generational transition: Starting January 1, 2026, Jan Wachtel will become CEO and help shape the company’s future.
Veranova has appointed Joe Torres-Ocasio as its new Senior Vice President and COO. He will lead global manufacturing and supply chain operations.
On December 1, Veronika Schaller will take over as editor-in-chief of DONNA and myself. Dr. Sabine Hofmann is stepping down after many successful years.
AGF Videoforschung has restructured its Supervisory Board: Matthias Eckert takes over as Chairman, while Kristina Bulle and Carsten Kollmus bring in new perspectives.
As of May 2026, Kai Beckmann will take over as CEO and Chair of the Executive Board of Merck. He succeeds Belén Garijo, who has successfully led the company since 2021.
Since September 2025, Claudia Hartmann has been responsible as Director International Sales & Partner Management for Engelhard Arzneimittel’s global sales strategy. With this move, the company signals its next growth phase.
On January 1, 2026, Franziska Erdle will succeed Dr. Sebastian Schmitz as ABDA CEO, bringing extensive association leadership experience.
On January 1, 2026, Andrea Bannert will assume the role of Editor-in-Chief of FOCUS Health, succeeding Andrea Hennis, who is retiring.
From September 1, 2025, Margit Pratschko will lead the pharmacy customer magazine My life alone – Silvia von Maydell is retiring.
Starting in September 2025, Dagmar Brandenstein will become the new Managing Director of bvitg Service GmbH and drive the strategic development of DMEA.
After nearly three years at the helm, Tobias Conrad is leaving cross-media marketer BCN for personal reasons, handing leadership to a dual management team.
Effective September 1, 2025, Dr. Carla Kriwet will succeed Dr. Hadi Saleh as CEO of the CeramTec Group. Saleh will join the Supervisory Board in January.
With Jean-Michel Quinot as new COO, AOP Health is strengthening its international leadership – with ambitious growth plans including U.S. market entry by 2030.
Nathan Licht joins the PEIX Health Group after three years at Capgemini and will now drive internal digitalization projects in close collaboration with management.
Haleon strengthens its leadership team with the appointment of Carl Haney as Chief R&D Officer. He will take on the role starting August 1, 2025.
Starting in October, Jörg Störmer will head the Procurement Management department at Klinikum Region Hannover, bringing extensive industry experience.
With Ellen Goel, the Life Science Factory welcomes a new Managing Director. She brings entrepreneurial spirit, experience, and passion for life sciences.
